A team of researchers from the University of Bradford, UK, are pioneering the use of computer models to design ways of infusing drugs through the skin - without the pain of needles. Their method could help develop stick-on skin patches for many drugs that currently have to be injected, such as insulin for diabetes.
The group's work will be reported on April 3 at the Eighth Annual Meeting of the Skin Forum taking place at the School of Pharmacy, University of London.
Few drugs can be delivered using such patches, because the molecules are too large to pass through the skin's tough barrier. But why this happens is not entirely understood, and investigating it is a challenge - despite being too large to pass through the skin, molecules of both kinds are still too small to be studied in experiments.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze